WELCOME TO THE

DELVE BLOG

Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle

—Not the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020—impacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment.

Privacy Concerns Surrounding Real-World Data

The Food and Drug Administration has officially taken the position that real-world data (RWD) and real-world evidence (RWE) are playing a larger role in health

Are Wearables the Future of Clinical Research?

“Wearables” (i.e., Apple Watch, FitBit, etc.) are a technology that is relatively new to the clinical research enterprise. These devices hold untapped potential regarding their

Clinical Trial Solutions That Can Help

Societies across the globe have embraced technology in almost every aspect of daily life. It leaves every industry wondering how to incorporate technology into our

Implementing eConsent in Clinical Trials

At Delve Health, we took extensive measures to develop a scalable eConsent solution that can be integrated with various solutions to streamline the data flow.

Scroll to Top